The Compound Report is an educational resource. Nothing on this site constitutes medical advice or encourages personal use of any compound. Always consult a qualified healthcare provider.
The cosmetic repair triple — skin, hair, and healing combined
GHK-Cu has human RCT data for topical use but not injectable. The combination has no human trial data of any kind.
Each individual component has some evidence basis. The combination has none. GHK-Cu's injectable evidence is zero RCTs — the topical data gets cited to justify the injectable protocol, which is a significant extrapolation. GLOW asks users to trust three separate extrapolations simultaneously.
What each compound contributes — and why it's in the stack.
Collagen synthesis, extracellular matrix remodeling, skin/hair gene expression reset
Full GHK-Cu chapterVascular repair, angiogenesis, gut protection, connective tissue healing
Full BPC-157 chapterSystemic anti-inflammation, progenitor cell mobilization, actin regulation
Full TB-500 chapterGLOW extends the Wolverine Stack by adding GHK-Cu's collagen-synthesis and gene-expression effects on top of the BPC-157/TB-500 healing foundation. The rationale is that GHK-Cu modulates extracellular matrix and skin-aging gene programs while BPC-157 and TB-500 drive the underlying vascular and inflammatory repair. The name "GLOW" reflects the cosmetic endpoints the community targets: skin texture, hair quality, and the general appearance-improvement often reported by long-cycle users.
This reflects how this combination is used in practice. It is not a prescribing guide and does not constitute medical advice.
| Phase | Timing | Compounds & doses | Notes |
|---|---|---|---|
| Vial blend option | All-in-one | Community protocol: combine GHK-Cu + BPC-157 in a single vial reconstituted with BAC water; draw one shot daily. TB-500 stays separate (different dosing frequency). | Mixing peptides in one vial is practical but not formally validated for stability. Keep refrigerated, use within 30 days. |
| Cycle (weeks 1–8) | Daily | GHK-Cu 1–2 mg SC + BPC-157 250–500 mcg SC + TB-500 2–2.5 mg SC/IM 1–2×/week | All three run concurrently. Some protocols load GHK-Cu higher (2–3 mg) in the first 2 weeks. |
| Cycle off (4+ weeks) | — | Monitor serum copper at end of cycle if running GHK-Cu for >8 weeks. | Copper accumulation is the primary monitoring target for GLOW given the GHK-Cu component. |
Users seeking combined cosmetic and systemic repair benefits — most commonly women interested in skin and hair improvements who also have or have had connective tissue injuries. Also athletes who want the Wolverine benefits plus a cosmetic layer.
Informational only. Ranges vary significantly by vendor, vial size, and country. No pharmaceutical-grade source exists for most of these compounds; figures are not a buying guide.